Fundamental Analysis
100 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +334.9% | +208.5% | 3 / 3 | +48.1% | +5.00 pp | +5.71 pp | +23.5% | 0.66 | 5.48 | 235 | +48,1% | 20,3 | +334,9% | 5.48 | 9.49 | −42,3% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 19.650 (close price on 2026-10-19)EPS (TTM): 3.588
Financial charts
1.Revenue & growth
VND bn229Q2/26
1.Revenue & growth
VND bn229Q2/26
2.Profit & growth
VND bn20,6Q2/26
3.Profit mix (Penman)
VND bn54,2Q2/26
4.Margins & cost structure
%10.7%Q2/26
5.Returns & cash cycle
% · days13.6%Q2/26
6.Earnings quality & cash
VND bn-59,4Q2/26
7.Asset structure
VND bn447Q2/26
8.Funding & debt health
VND bn · times447Q2/26
9.Revenue backlog
VND bn24,3Q2/26
10.Valuation
times · %5,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.716Q2/26
Adjusted EPS growth, latest quarter
341%
Average adjusted EPS growth, 3 quarters
210%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26